Global Hemostasis Diagnostics Market Worth USD 7.3 Billion By 2024: Zion Market Research

According to the report, the global hemostasis diagnostics market was valued at approximately USD 4.2 billion in 2017 and is expected to generate revenue of around USD 7.3 billion by 2024, at a CAGR of around 8.1% between 2018 and 2024.

New York, NY, Jan. 14, 2019 (GLOBE NEWSWIRE) — Zion Market Research has published a new report titled “Hemostasis Diagnostics Market by Product Type (Laboratory Systems, Consumables, and Point-of-Care Testing Systems), by Test Type (Prothrombin Test Time (PT), Activated Partial Thromboplastin Time (APTT), Fibrinogen Degradation Products (FDP), Activated Clotting Time, Platelet Aggregation Test, and D Dimer), and by End-User (Hospital & Clinics, Independent Diagnostic Laboratories, and Home Care Settings): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017—2024”. According to the report, the global hemostasis diagnostics market was valued at approximately USD 4.2 billion in 2017 and is expected to generate revenue of around USD 7.3 billion by 2024, at a CAGR of around 8.1% between 2018 and 2024. 

Hemostasis is a process of slowing down or stopping bleeding from damaged blood vessels during this process the blood changes from liquid to a gelatinous state. It is the first stage of wound healing. Hemostasis devices are used to detect hemostatic defects that can lead to excessive bleeding. Thus, to achieve hemostasis during emergencies, various chemical agents are used to stop bleeding as the hemorrhage can be life-threatening for the patient.

Browse through 54 Tables & 15 Figures spread over 110 Pages and in-depth TOC on “Global Hemostasis Diagnostics Market: By Type, Size, Share, Industry Growth Analysis and Forecast, 2017—2024”.

Request Free Sample Report of Global Hemostasis Diagnostics Market Report @ https://www.zionmarketresearch.com/sample/hemostasis-diagnostics-market

The major factor that is likely to drive the hemostasis diagnostics market over the forecast timeframe is the increased prevalence of hemostasis disorders. The increased occurrence of genetically inherited diseases is likely to fuel the hemostasis diagnostics market in the foreseeable future. Moreover, high investment in research and development is projected to drive the development of new and advanced products over the estimated years. However, the high cost of advanced hemostasis devices and stringent regulatory policies regarding the approval of these diagnostics might hamper the hemostasis diagnostics market in the future.

The hemostasis diagnostics market is classified into product type, end user, and test type. By product type, the hemostasis diagnostics market is segmented into laboratory systems, consumables, and point-of-care testing systems. Laboratory systems are expected to dominate the hemostasis diagnostic market in the future. By test type, the hemostasis diagnostics market is segmented into prothrombin test time (PT), activated partial thromboplastin time (APTT), fibrinogen degradation products (FDP), activated clotting time, platelet aggregation test, and D dimer. Prothrombin test time is expected to dominate the market over the estimated time period. By end-user, the hemostasis diagnostics market is segmented into hospital and clinics, independent diagnostic laboratories, and home care settings. Hospitals and clinics are likely to dominate the market over the forecast time period.

Download Free Report PDF Brochure: https://www.zionmarketresearch.com/requestbrochure/hemostasis-diagnostics-market

By region, the hemostasis diagnostics market includes North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to dominate the global hemostasis diagnostics market over the forecast timeline, owing to the presence of developed countries, such as the U.S. and Canada, increased prevalence of hemostasis disorders, and advanced healthcare facilities and infrastructure are expected to promote the growth of hemostasis diagnostics market over the forecast timeline.

Europe is likely to be the second leading region in this global market over the forecast timeframe and closely follow North America in terms of revenue. The presence of advanced research and development facilities across the region and the substantial technological developments are expected to propel the region’s hemostasis diagnostics market in the future.

Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/hemostasis-diagnostics-market

The Asia Pacific hemostasis diagnostics market is expected to grow rapidly over the forecast time period, owing to the presence of developing economies, such as India and China and the introduction of advanced healthcare facilities in the region. Furthermore, the increased prevalence of various hemostasis disorders, the presence of regional and international market players, and massive investments in R&D across the region are expected to contribute notably toward the region’s hemostasis diagnostics market in the upcoming years.

The Latin American and the Middle Eastern and African markets are expected to expand at a moderate rate over the forecast time period, due to the increased awareness among people and development of healthcare and medical facilities across the region. Furthermore, the increase in economic growth is also likely to fuel these regional markets in the upcoming years.

Browse the full “Hemostasis Diagnostics Market by Product Type (Laboratory Systems, Consumables, and Point-of-Care Testing Systems), by Test Type (Prothrombin Test Time (PT), Activated Partial Thromboplastin Time (APTT), Fibrinogen Degradation Products (FDP), Activated Clotting Time, Platelet Aggregation Test, and D Dimer), and by End-User (Hospital & Clinics, Independent Diagnostic Laboratories, and Home Care Settings): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017—2024” Report at https://www.zionmarketresearch.com/report/hemostasis-diagnostics-market

The major players of the global hemostasis diagnostics market include Siemens Healthineers, Abbott Laboratories, Instrumentation Laboratory, Thermo Fisher Scientific Inc., Alere Inc., Nihon Kohden Corporation, Sysmex Corporation, Danaher Corporation, F. Hoffmann-La Roche Ltd., and Grifols S.A.

Request customized copy of report @ https://www.zionmarketresearch.com/custom/3726

This report segments the global hemostasis diagnostics market into:

Global Hemostasis Diagnostics Market: Product Type Analysis

  • Laboratory Systems
  • Consumables
  • Point-of-Care Testing Systems

Global Hemostasis Diagnostics Market: Test Type Analysis

  • Prothrombin Test Time (PT)
  • Activated Partial Thromboplastin Time (APTT)
  • Fibrinogen Degradation Products (FDP)
  • Activated Clotting Time
  • Platelet Aggregation Test
  • D Dimer

Global Hemostasis Diagnostics Market: End-User Analysis

  • Hospital and Clinics
  • Independent Diagnostic Laboratories
  • Home Care Settings

Global Hemostasis Diagnostics Market: Regional Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Related Reports:

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research
Follow Us Twitter: https://twitter.com/zion_research

Blog: http://usindustrynews.com | http://europeindustrynews.com | http://zmrresearchnews.us | http://zmrnewsanalysis.com

Contact Us:

Joel John
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com

Website: https://www.zionmarketresearch.com

Blog: http://zmrblog.com

Share this post